Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13208-13215
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13208
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13208
Figure 2 Comparison of complement levels (g/L) between the hypersplenism group and the control group.
aP < 0.05; bP < 0.001.
- Citation: Zhang K, Zeng M, Li YJ, Wu HF, Wu JC, Zhang ZS, Zheng JF, Lv YF. Antibody and complement levels in patients with hypersplenism associated with cirrhotic portal hypertension and therapeutic principles. World J Clin Cases 2022; 10(36): 13208-13215
- URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13208.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13208